RIP140-Mediated NF-κB Inflammatory Pathway Promotes Metabolic Dysregulation in Retinal Pigment Epithelium Cells

Zeli Guo1, Yuli Shen1, Jianwen Zhong1

  • 1State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou 510060, China.

Insights

RIP140 dysregulates retinal pigment epithelium (RPE) metabolism, inhibiting mitochondrial ATP production and promoting inflammation. Modulating RIP140 may offer therapeutic strategies for age-related macular degeneration (AMD) by preventing RPE degeneration.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Metabolic Research

Background:

  • Metabolic dysfunction in the retinal pigment epithelium (RPE) is linked to age-related macular degeneration (AMD).
  • The precise molecular mechanisms governing RPE metabolism are not fully understood.
  • RIP140 is a known regulator of oxidative metabolism and mitochondrial biogenesis, negatively impacting pathways controlled by PGC-1α.

Purpose of the Study:

  • To investigate the role of RIP140 in regulating the metabolic program of RPE cells.
  • To explore the effects of RIP140 on RPE metabolism both in vitro and in vivo.

Main Methods:

  • Western blotting for RIP140 protein levels.
  • Quantitative real-time PCR (qRT-PCR) for gene expression analysis.
  • Assays for ATP production, glycogen concentration, and inflammatory factor release (IL-1β, IL-6, TNF-α).
  • Electroretinography (ERG) to measure photoreceptor function in vivo.

Main Results:

  • RIP140 overexpression in ARPE-19 cells altered metabolic and lipid processing gene expression.
  • Inhibition of mitochondrial ATP production and enhancement of glycogenesis were observed with RIP140 overexpression.
  • RIP140 promoted NF-κB translocation and increased inflammatory cytokine production (IL-1β, IL-6, TNF-α).
  • Adenovirus-mediated RIP140 overexpression in rat retinal cells reduced ERG a-wave and b-wave amplitudes.

Conclusions:

  • RIP140 significantly impacts RPE metabolic pathways, including mitochondrial function and glucose metabolism.
  • RIP140 overexpression exacerbates RPE inflammation and dysfunction.
  • Targeting RIP140 activity presents a potential therapeutic avenue for managing RPE degeneration in AMD.